Nuwellis (NUWE) Other Accumulated Expenses (2016 - 2026)
Nuwellis' (NUWE) quarterly Other Accumulated Expenses came in at $68000.0 in Q2 2026, down 8.11% on a YoY basis from $74000.0 in Q2 2025, and down 4.23% quarter-over-quarter from $71000.0 in Q1 2026.
Analysis
Nuwellis (NUWE) Other Accumulated Expenses (2016 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Other Accumulated Expenses for 11 consecutive years, with $68000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Accumulated Expenses fell 8.11% year-over-year to $68000.0; the trailing twelve-month figure through Jun 2026 stood at $68000.0 (down 8.11% YoY), and the FY2025 full-year result was $85000.0, up 107.32% from the prior year.
- Other Accumulated Expenses declined to $68000.0 in Q2 2026 per NUWE's latest filing, from $71000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $86000.0 in Q1 2025 and bottomed at $41000.0 in Q4 2024.
- Historically, Other Accumulated Expenses has averaged $61444.4 across 5 years, with a median of $59000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses tumbled 38.36% in 2023, then jumped 107.32% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $58000.0 in 2022, then fell by 12.07% to $51000.0 in 2023, then declined by 19.61% to $41000.0 in 2024, then surged by 107.32% to $85000.0 in 2025, then declined by 20.0% to $68000.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $68000.0, $71000.0, and $85000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68,000.00 |
| Mar 31, 2026 | 71,000.00 |
| Dec 31, 2025 | 85,000.00 |
| Sep 30, 2025 | 76,000.00 |
| Jun 30, 2025 | 74,000.00 |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Sep 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 60,000.00 |
| Mar 31, 2023 | 49,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 63,000.00 |
| Mar 31, 2022 | 55,000.00 |
| Dec 31, 2021 | 36,000.00 |
| Sep 30, 2021 | 38,000.00 |